Biomarkers In Drug Discovery & Development 2012, 10-11 September, Berlin, Germany

Date: Jul-04-2012At this specific event participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are enthusiastic about sharing their knowledge, experience and practices and provide further advices and fresh ideas to their business peers.

The discussion topics will be focused mainly on:
The latest technologies for biomarker identification
Methods to discover robust biomarkers for pharmacodynamic and
predictive purposes
Contribution of imaging to decision-making in drug development
Successful application of biomarkers in various therapeutic areas
- moving towards a personalized medicine approach

In order to get deeper into the discussed topics and look at the burning issues from different angles, presentations will be complemented with real-life case studies and interactive sessions. Practical round table discussions beginning with short brainstorming sessions will allow participants to categorize the brainstorming feedback into main discussion topics, and provide the attendees the opportunity to choose a round table discussion that best fits their interest.

This conference is designed for:

Senior Vice Presidents, Chief Scientific Officers, Vice Presidents, Heads, Directors, Scientists, Researchers, Investigators, Professors in:

Biomarkers, Clinical Research, Drug Discovery and Development, Translational Research / Science / Imaging, Molecular Imaging, Experimental Medicine, Clinical Pharmacology, Molecular Toxicology, "Omics" Programmes, Clinical Discovery Technologies, Diagnostics, Biomarker Strategy, Assay Development, Pathway Analysis, Regulatory Affairs, etc.

Are you interested in exploring the best practices in accelerating the identification of drug targets, reducing the overall costs of the drug development process as well as the likelihood of adverse events? Do you want to seize the opportunity to gain strategic contacts and valuable information? Then do not hesitate and join us in Berlin.

Organized by Fleming Europe:

Biomarkers in Drug Discovery & Development 2012

10-11 September 2012

Berlin, Germany

Learn more at http://pharma.flemingeurope.com/biomarkers
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.